Loading...
Please wait, while we are loading the content...
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
| Content Provider | Semantic Scholar |
|---|---|
| Author | Cholankeril, George Patel, Ronak M. Khurana, Sandeep Satapathy, Sanjaya K. |
| Copyright Year | 2017 |
| Abstract | With the prevalence of hepatitis C virus expected to decline, the proportion of hepatocellular carcinoma (HCC) related to non-alcoholic steatohepatitis (NASH) is anticipated to increase exponentially due to the growing epidemic of obesity and diabetes. The annual incidence rate of developing HCC in patients with NASH-related cirrhosis is not clearly understood with rates ranging from 2.6%-12.8%. While multiple new mechanisms have been implicated in the development of HCC in NASH; further prospective long-term studies are needed to validate these findings. Recent evidence has shown a significant proportion of patients with non-alcoholic fatty liver disease and NASH progress to HCC in the absence of cirrhosis. Liver resection and transplantation represent curative therapeutic options in select NASH-related HCC patients but have placed a significant burden to our healthcare resources and utilization. Currently NASH-related HCC is the fastest growing indication for liver transplant in HCC candidates. Increased efforts to implement effective screening and preventative strategies, particularly in non-cirrhotic NASH patients, are needed to reduce the future impact imposed by NASH-related HCC. |
| Starting Page | 533 |
| Ending Page | 543 |
| Page Count | 11 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://pdfs.semanticscholar.org/7eba/166c3a17c22a7cfed3ada7b8d99c4a5abd22.pdf |
| PubMed reference number | 28469809v1 |
| Alternate Webpage(s) | https://doi.org/10.4254/wjh.v9.i11.533 |
| DOI | 10.4254/wjh.v9.i11.533 |
| Journal | World journal of hepatology |
| Volume Number | 9 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Alcoholic Liver Diseases Chemical and Drug Induced Liver Injury Diabetes Mellitus Fatty Liver, Alcoholic Fibrosis Hepatectomy Hepatitis C virus Hepatitis C, Chronic Liver carcinoma Non-alcoholic Fatty Liver Disease Obesity Patients Steatohepatitis Transplantation of liver non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia |
| Content Type | Text |
| Resource Type | Article |